The SLC9A1 mRNA expression level was not associated with altered survival for the whole population of breast cancer patients (Figure 9B) or for breast cancer patients suffering from normal-like (Figure 9C), luminal B (Figure 9E), HER2-enriched (Figure 9F), or basal-like (Figure 9G) breast cancer. Here, ERBB2 is linked to breast carcinoma.